Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Roger Justin Charles, MD, is a Staff Physician in the Department of Gastroenterology at Cleveland Clinic Florida. Subsequent to his current appointment, he was Regional Chief of Gastroenterology at Kaiser Permanente Ohio. Dr. Charles is board-certified in gastroenterology and internal medicine.
After receiving his Bachelor of Medicine/Bachelor of Surgery in 1990, Dr. Charles completed his residency at Cleveland Clinic. His research and clinical interests include general gastroenterology, general hepatology, capsule endoscopy, double balloon enteroscopy, obscure GI bleeding, hepatitis C, diagnostic and therapeutic endoscopy and diseases of the small bowel.
Dr. Charles is the recipient of an array of academic awards, including the Dr. Sidney Garfield Physician of Excellence Award, a teaching award presented by the internal medicine residents at Case Western Reserve University Hospital in Cleveland, Ohio, and an Outstanding Senior Medical Resident Award from Cleveland Clinic. He was awarded a subject medal and distinction in pharmacology and physiology in 1989.
He is a member of the American Gastroenterology Association, the American Society for Gastrointestinal Endoscopy, the American College of Gastroenterology and the American College of Physicians. In addition to his clinical practice and teaching appointments, Dr. Charles contributes to Gastrointestinal Endoscopy, a peer-reviewed medical journal, and he has authored a variety of abstracts and posters.
General Gastroenterology and Hepatology, Capsule endoscopy, Double Balloon Enteroscopy, Spirus Enteroscopy, Obscure GI bleeding, Diseases of the Small bowel, Diagnostic and Therapeutic Endoscopy, Inflammatory Bowel Disease
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 11/4/2013, Dr. Charles has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.